Header Logo

Connection

Bruno Pagnin Schmid to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Bruno Pagnin Schmid has written about Cost-Benefit Analysis.
Bruno Pagnin Schmid
Connection Strength
0.393
Cost-Benefit Analysis
  1. Cost-effectiveness of radiofrequency ablation versus percutaneous ethanol injection for early hepatocellular carcinoma in a resource-poor setting: a randomized trial. Einstein (Sao Paulo). 2024; 22:eGS0683.
    View in: PubMed
    Score: 0.393
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.